Westkaemper RB, Runyon SP, Bondarev ML, Savage JE, Roth BL, Glennon RA. 9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist. European Journal of Pharmacology. September 1999, 380 (1): R5–7. PMID 10513561. doi:10.1016/S0014-2999(99)00525-7.
Runyon SP, Peddi S, Savage JE, Roth BL, Glennon RA, Westkaemper RB. Geometry-affinity relationships of the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene. Journal of Medicinal Chemistry. April 2002, 45 (8): 1656–64. PMID 11931619. doi:10.1021/jm010354g.
Peddi S, Roth BL, Glennon RA, Westkaemper RB. Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist. European Journal of Pharmacology. December 2003, 482 (1–3): 335–7. PMID 14660041. doi:10.1016/j.ejphar.2003.09.059.
Peddi S, Roth BL, Glennon RA, Westkaemper RB. Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA). Bioorganic & Medicinal Chemistry Letters. May 2004, 14 (9): 2279–83. PMID 15081025. doi:10.1016/j.bmcl.2004.02.014.
Westkaemper RB, Runyon SP, Bondarev ML, Savage JE, Roth BL, Glennon RA. 9-(Aminomethyl)-9,10-dihydroanthracene is a novel and unlikely 5-HT2A receptor antagonist. European Journal of Pharmacology. September 1999, 380 (1): R5–7. PMID 10513561. doi:10.1016/S0014-2999(99)00525-7.
Runyon SP, Peddi S, Savage JE, Roth BL, Glennon RA, Westkaemper RB. Geometry-affinity relationships of the selective serotonin receptor ligand 9-(aminomethyl)-9,10-dihydroanthracene. Journal of Medicinal Chemistry. April 2002, 45 (8): 1656–64. PMID 11931619. doi:10.1021/jm010354g.
Peddi S, Roth BL, Glennon RA, Westkaemper RB. Spiro[9,10-dihydroanthracene]-9,3'-pyrrolidine-a structurally unique tetracyclic 5-HT2A receptor antagonist. European Journal of Pharmacology. December 2003, 482 (1–3): 335–7. PMID 14660041. doi:10.1016/j.ejphar.2003.09.059.
Peddi S, Roth BL, Glennon RA, Westkaemper RB. Structural determinants for high 5-HT(2A) receptor affinity of spiro[9,10-dihydroanthracene]-9,3(')-pyrrolidine (SpAMDA). Bioorganic & Medicinal Chemistry Letters. May 2004, 14 (9): 2279–83. PMID 15081025. doi:10.1016/j.bmcl.2004.02.014.